OPX Biotechnologies

OPX Biotechnologies

Developing and commercializing cost effective bio.

Information, communication & technology | Northern America | Energy and Fuel Efficiency

 

Overview

OPXBIO uses its proprietary leading EDGE (Efficiency Directed Genome Engineering) technology to manufacture renewable bio based chemicals and fuels that are lower cost higher return and more sustainable than existing petroleum based products. In addition to DBL Investors investors includeX/Seed Capital USRG Mohr Davidow Braemar Energy Ventures and Wolfensohn & Co.

Industry

Legal Structure

Operating Status

Employees

Information, communication & technology Acquired 51 - 200 employees

Funding and Financing Rounds


Team


Impact

Geographies:

Social Objectives:

Environmental Objectives:

Operational Impact:


Impact Reports & Metrics


Offices

Headquarters

2425 55th Street, Suite 100
Boulder, Colorado 80301
United States of America



Explore

Revision History

Last Update: Sep 03, 2017 12:24 p.m.

Quick Search



  • Global  
  • Africa  
  • Americas  
  • Asia  
  • Europe  
  • Oceania  


Incoming

Tags

COPYRIGHT 2018 IMPACTSPACE. ALL RIGHTS RESERVED.